What price will be used when drug prices are required in direct to consumer ads?

The U.S. Senate passed an amendment to the spending bill that would require pharma companies to disclose the prices of any products they advertise directly to consumers (DTC). However, the question is: Which price would drug makers be required to disclose in their direct-to-consumer ads and whether this information would actually mean anything to consumers since the fact that the consumer actual out-of-pocket price would be set by their health insurer. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.